86 related articles for article (PubMed ID: 8525258)
1. [Severe combined immunodeficiency: description of a clinical case].
Dantas EO; Alves FP; Marques AP; Rodrigues AM; Pastorino AC; Jacob CM; Grumach AS
Rev Hosp Clin Fac Med Sao Paulo; 1995; 50(3):160-3. PubMed ID: 8525258
[TBL] [Abstract][Full Text] [Related]
2. Severe combined immunodeficiency: a national surveillance study.
Yee A; De Ravin SS; Elliott E; Ziegler JB;
Pediatr Allergy Immunol; 2008 Jun; 19(4):298-302. PubMed ID: 18221464
[TBL] [Abstract][Full Text] [Related]
3. Omenn syndrome: a rare case of neonatal erythroderma.
Puzenat E; Rohrlich P; Thierry P; Girardin P; Taghian M; Ouachee M; Plouvier E; Fischer A; Humbert P; Aubin F
Eur J Dermatol; 2007; 17(2):137-9. PubMed ID: 17337397
[TBL] [Abstract][Full Text] [Related]
4. Clinical application of DNA microarrays: molecular diagnosis and HLA matching of an Amish child with severe combined immune deficiency.
Strauss KA; Puffenberger EG; Bunin N; Rider NL; Morton MC; Eastman JT; Morton DH
Clin Immunol; 2008 Jul; 128(1):31-8. PubMed ID: 18442948
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy for severe combined immune deficiency.
Qasim W; Gaspar HB; Thrasher AJ
Expert Rev Mol Med; 2004 Jul; 6(13):1-15. PubMed ID: 15236670
[TBL] [Abstract][Full Text] [Related]
6. Mutation analysis should be performed to rule out gammac deficiency in children with functional severe combined immune deficiency despite apparently normal immunologic tests.
Somech R; Roifman CM
J Pediatr; 2005 Oct; 147(4):555-7. PubMed ID: 16227049
[TBL] [Abstract][Full Text] [Related]
7. Abnormal development of thymic dendritic and epithelial cells in human X-linked severe combined immunodeficiency.
Hale LP; Buckley RH; Puck JM; Patel DD
Clin Immunol; 2004 Jan; 110(1):63-70. PubMed ID: 14962797
[TBL] [Abstract][Full Text] [Related]
8. X-linked SCID and other defects of cytokine pathways.
Uribe L; Weinberg KI
Semin Hematol; 1998 Oct; 35(4):299-309. PubMed ID: 9801259
[TBL] [Abstract][Full Text] [Related]
9. [Gene therapy of severe combined immunodeficiency disease: proof of principle of efficiency and safety issues. Gene therapy, primary immunodeficiencies, retrovirus, lentivirus, genome].
Fischer A; Hacein-Bey-Abina S; Lagresle C; Garrigue A; Cavazana-Calvo M
Bull Acad Natl Med; 2005 May; 189(5):779-85; discussion 786-8. PubMed ID: 16433450
[TBL] [Abstract][Full Text] [Related]
10. [Severe combined immunodeficiencies: a case of adenosine-deaminase deficit].
Macellaro P; Savarino A; Cucchi G; Lazzati A; Zuccotti GV
Pediatr Med Chir; 2004; 26(3):191-5. PubMed ID: 16366403
[TBL] [Abstract][Full Text] [Related]
11. Successful pregnancy in a patient with severe combined immunodeficiency syndrome treated with bone marrow transplantation.
Shrivastava VK; Arora N; Simpson EL; Wing DA
Obstet Gynecol; 2008 Aug; 112(2 Pt 2):439-41. PubMed ID: 18669756
[TBL] [Abstract][Full Text] [Related]
12. Failure to thrive in a 14-month-old boy with lymphopenia and eosinophilia.
Härtel C; Strunk T; Bucsky P; Schultz C
Klin Padiatr; 2004; 216(1):24-5. PubMed ID: 14747967
[TBL] [Abstract][Full Text] [Related]
13. Cost analysis of treatments for severe combined immunodeficiency patients caused by adenosine deaminase deficiency: comparison of gene therapy and bone marrow transplantation.
Imai H
Hokkaido Igaku Zasshi; 1998 Mar; 73(2):137-45. PubMed ID: 9612707
[TBL] [Abstract][Full Text] [Related]
14. Cognitive and behavioral abnormalities in adenosine deaminase deficient severe combined immunodeficiency.
Rogers MH; Lwin R; Fairbanks L; Gerritsen B; Gaspar HB
J Pediatr; 2001 Jul; 139(1):44-50. PubMed ID: 11445793
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow transplantation for T-B- severe combined immunodeficiency disease in Athabascan-speaking native Americans.
O'Marcaigh AS; DeSantes K; Hu D; Pabst H; Horn B; Li L; Cowan MJ
Bone Marrow Transplant; 2001 Apr; 27(7):703-9. PubMed ID: 11360109
[TBL] [Abstract][Full Text] [Related]
16. [Early recognition and successful treatment of an infant with severe combined immune deficiency].
Mosdósi B; Decsi T; Nagy K; Soltész G; Maródi L
Orv Hetil; 2002 Sep; 143(36):2081-3. PubMed ID: 12378899
[TBL] [Abstract][Full Text] [Related]
17. Polysaccharide antibody responses are impaired post bone marrow transplantation for severe combined immunodeficiency, but not other primary immunodeficiencies.
Slatter MA; Bhattacharya A; Flood TJ; Spickett GP; Cant AJ; Abinun M; Gennery AR
Bone Marrow Transplant; 2003 Jul; 32(2):225-9. PubMed ID: 12838289
[TBL] [Abstract][Full Text] [Related]
18. T cell depleted haploidentical bone marrow transplantation for the treatment of children with severe combined immunodeficiency.
Smogorzewska EM; Brooks J; Annett G; Kapoor N; Crooks GM; Kohn DB; Parkman R; Weinberg KI
Arch Immunol Ther Exp (Warsz); 2000; 48(2):111-8. PubMed ID: 10807052
[TBL] [Abstract][Full Text] [Related]
19. Gnotobiotics and immunopathology: the use of the gnotobiotic environment to study acquired and inherited immunodeficiency diseases.
Krakowka S; Felsburg P
Vet Immunol Immunopathol; 2005 Oct; 108(1-2):165-75. PubMed ID: 16112740
[TBL] [Abstract][Full Text] [Related]
20. Severe combined immunodeficiency caused by deficiency in either the delta or the epsilon subunit of CD3.
de Saint Basile G; Geissmann F; Flori E; Uring-Lambert B; Soudais C; Cavazzana-Calvo M; Durandy A; Jabado N; Fischer A; Le Deist F
J Clin Invest; 2004 Nov; 114(10):1512-7. PubMed ID: 15546002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
